Skip to main content
Explore URMC


A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema

Research Question:
Does the drug faricimab help patients with macular edema due to diabetes?

Basic Study Information

This study will evaluate the efficacy, safety, and pharmacokinetics of faricimab administered at 8-week intervals or as specified in the protocol following treatment initiation, compared with aflibercept once every 8 weeks (Q8W), in participants with diabetic macular edema (DME).

Location: Retina Assoc of Western NY

Lead Researcher (Principal Investigator)

Lead Researcher: Ajay Kuriyan

Study Contact Information

Study Coordinator: Reference Study ID Number: GR40398
Phone: (888) 662-6728

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search